Despite some skepticism over the rollout of the vaccine, some governments have suggested that it could be available as soon as next month if it gets fast track approval.

According to Barry Norris of Argonaut Capital Partners, an expert on the biotech sector, the announcement could have been made sooner and was likely delayed so that Trump couldn’t take full credit.



Read more…